Cozad Asset Management’s Takeda Pharmaceutical TAK Stock Holding History

Cozad Asset Management’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-10,521	Closed	-$150K	–	415
2024 Q3	$150K	Buy	10,521 +341	+3%	+$4.84K	0.01%	402
2024 Q2	$132K	Hold	10,180	–	–	0.01%	394
2024 Q1	$141K	Sell	10,180 -2,382	-19%	-$34.6K	0.01%	389
2023 Q4	$179K	Hold	12,562	–	–	0.02%	375
2023 Q3	$194K	Sell	12,562 -309	-2%	-$4.78K	0.03%	364
2023 Q2	$202K	Hold	12,871	–	–	0.03%	362
2023 Q1	$212K	Hold	12,871	–	–	0.03%	351
2022 Q4	$201K	Hold	12,871	–	–	0.03%	360
2022 Q3	$167K	Buy	+12,871	New	+$179K	0.03%	340
2020 Q3	–	Sell	-10,156	Closed	-$182K	–	332
2020 Q2	$182K	Buy	+10,156	New	+$182K	0.04%	316

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Cozad Asset Management's TAK Position: Q4 2024 in Review

Cozad Asset Management sold out of Takeda Pharmaceutical (TAK) in Q4 2024, closing a stake of 10,521 shares — an estimated $150K sold.

Cozad Asset Management first reported a position in TAK in Q2 2020 and held it in 10 quarters. The position peaked at $212K in Q1 2023. 299 funds tracked by Wall St. Rank hold TAK as of Q4 2024.

Cozad Asset Management reported no remaining Takeda Pharmaceutical position as of Q4 2024 after selling out during the quarter.
Cozad Asset Management sold 10,521 Takeda Pharmaceutical shares in Q4 2024, an estimated $150K.
Cozad Asset Management first reported a position in Takeda Pharmaceutical in Q2 2020 and held it in 10 quarters.
Cozad Asset Management's Takeda Pharmaceutical position peaked at $212K in Q1 2023.
299 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q4 2024.

Based on Cozad Asset Management's 13F filing for Q4 2024, filed 10 Feb 2025.